Association of BRAFV600E mutation with ultrasonographic features and clinicopathologic characteristics of papillary thyroid microcarcinoma: A retrospective study of 116 cases

被引:12
|
作者
Chen, Baoding [1 ,3 ,4 ]
Zhang, Zheng [1 ]
Wang, Keke [1 ]
Shang, Mengyuan [1 ]
Zhao, Shuangshuang [1 ]
Ding, Wenbo [2 ]
Du, Rui [1 ]
Yu, Zhuan [1 ]
Xu, Ximing [3 ,4 ]
机构
[1] Jiangsu Univ, Dept Med Ultrasound, Affiliated Hosp, Zhenjiang, Jiangsu, Peoples R China
[2] Jiangsu Prov Hosp Integrat Chinese & Western Med, Dept Med Ultrasound, Zhenjiang, Peoples R China
[3] Jiangsu Univ, Sch Pharm, Dept Pharmaceut, Zhenjiang, Peoples R China
[4] Jiangsu Univ, Ctr Drug Gene Delivery & Tissue Engn, Zhenjiang, Peoples R China
关键词
BRAF(V600E) mutation; ultrasonographic features; clinicopathologic characteristics; papillary thyroid microcarcinoma; BRAF MUTATION; NODULES; ULTRASOUND; CARCINOMA; US;
D O I
10.3233/CH-190568
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: To analyze the association of BRAF(V600E) mutation with ultrasonographic (US) features and clinicopathologic characteristics in Chinese patients with papillary thyroid microcarcinoma (PTMC). METHODS AND MATERIALS: We retrospectively reviewed 116 consecutive Chinese patients with PTMC diagnosed by postoperative pathology. The incidence of the BRAF(V600E) mutation was calculated. The US features and clinicopathologic characteristics were compared between BRAF-positive and BRAF-negative patients. RESULTS: The BRAF(V600E) mutation was detected in 60.3% of patients (70 of 116). Multifocality (OR: 3.681, P = 0.031), non-parallel orientation (OR: 3.181, P = 0.041) and lymph node metastasis (OR: 4.615, P = 0.009) were significantly associated with BRAF(V600E) mutation. Other US and clinicopathologic characteristics were not significantly related to the presence of BRAF mutation. CONCLUSION: Multifocality, non-parallel orientation and cervical lymph node metastasis are risk factors for BRAF(V600E) mutation in PTMC. These factors potentially guide treatment planning or prognosis evaluation.
引用
收藏
页码:545 / 552
页数:8
相关论文
共 50 条
  • [31] Analysis of BRAFV600E Mutational Status and the Biology of Papillary Thyroid Microcarcinoma
    Han, Y.
    Sacks, W.
    Treml, A.
    Fan, X.
    Bose, S.
    Lopategui, J.
    Braunstein, G.
    Frishberg, D.
    MODERN PATHOLOGY, 2011, 24 : 137A - 137A
  • [32] BRAFV600E Mutation Is Highly Associated with Malignant Ultrasonographic Features in Korean Patients with Papillary Thyroid Cancer.
    Lee, E. J.
    Kim, D. L.
    Kim, S. K.
    Whang, T. S.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [33] Clinicopathologic Implications of the BRAFV600E Mutation in Papillary Thyroid Cancer: A Subgroup Analysis of 3130 Cases in a Single Center
    Lim, Jae Yun
    Hong, Soon Won
    Lee, Yong Sang
    Kim, Bup-Woo
    Park, Cheong Soo
    Chang, Hang-Seok
    Cho, Jae Yong
    THYROID, 2013, 23 (11) : 1423 - 1430
  • [34] Meta-Analyses of Association Between BRAFV600E Mutation and Clinicopathological Features of Papillary Thyroid Carcinoma
    Zhang, Qing
    Liu, Shao-zheng
    Zhang, Qing
    Guan, Yan-xing
    Chen, Qing-jie
    Zhu, Qin-yao
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2016, 38 (02) : 763 - 776
  • [35] A Significance of Concomitant BRAFV600E and TERT Mutations in Polish Patients with Papillary Thyroid Microcarcinoma: A Retrospective Cohort Study Based on 430 Cases
    Kuchareczko, Artur
    Kopczynski, Janusz
    Kowalik, Artur
    Hincza-Nowak, Kinga
    Walczyk, Agnieszka
    Palyga, Iwona
    Trybek, Tomasz
    Szymonek, Monika
    Gasior-Perczak, Danuta
    Gadawska-Juszczyk, Klaudia
    Mikina, Estera
    Plachta, Izabela
    Suligowska, Agnieszka
    Plusa, Agnieszka
    Chrapek, Magdalena
    Lopatynski, Tomasz
    Gozdz, Stanislaw
    Kowalska, Aldona
    THYROID, 2022, 32 (11) : 1372 - 1381
  • [36] BRAFV600E gene mutation can predict central lymph node metastasis in thyroid papillary microcarcinoma
    Zheng, Hai-Hong
    Gan, Mei-Fu
    Zhang, Ling-Na
    Wei, Ke-Na
    Xie, Bo-Jian
    KUWAIT MEDICAL JOURNAL, 2020, 52 (01): : 61 - 65
  • [37] BRAFV600E Mutation and Papillary Thyroid Cancer: Chicken or Egg?
    Xing, Mingzhao
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (07): : 2295 - 2298
  • [38] Clinical implication of the BRAFV600E mutation in papillary thyroid carcinoma
    Kim, Yong-Seok
    Kim, Jeong-Soo
    Bae, Ja-Seong
    Park, Woo-Chan
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2013, 11
  • [39] The BRAFV600E mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma
    Kim, TY
    Kim, WB
    Song, JY
    Rhee, YS
    Gong, GY
    Cho, YM
    Kim, SY
    Kim, SC
    Hong, SJ
    Shong, YK
    CLINICAL ENDOCRINOLOGY, 2005, 63 (05) : 588 - 593
  • [40] Papillary Thyroid Carcinoma With BRAFV600E Mutation: Sonographic Prediction
    Hwang, Jiyoung
    Shin, Jung Hee
    Han, Boo-Kyung
    Ko, Eun Young
    Kang, Seok Seon
    Kim, Jong-Won
    Chung, Jae Hoon
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2010, 194 (05) : W425 - W430